Atlas Trials

Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia

Clinical trial NCT01968486 · COMPLETED

Trial details

NCT number
NCT01968486
Sponsor
University of Campania Luigi Vanvitelli
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Myopia, Degenerative
Start date
2012-06-01
Primary completion
2013-07-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.